1,399 results on '"Siesling S."'
Search Results
2. Deintensification of Radiotherapy Use in Treatment of Ductal Carcinoma In Situ in the Netherlands–A Nationwide Overview From 2008 Until 2022
3. The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy
4. The Added Value of Physical Examination for Breast Cancer Recurrence Detection in Women: A Systematic Review
5. Shared decision-making supported by outcome information regarding surveillance after curative treatment for breast cancer: Results of the SHOUT-BC study
6. Radiotherapy Trends and Variations in Invasive Non-metastatic Breast Cancer Treatment in the Netherlands: A Nationwide Overview From 2008 to 2019
7. Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families
8. Colorectal cancer follow-up after surgical resection since the COVID-19 pandemic: first steps towards out-of-hospital follow-up?
9. Trends and Variation in the Use of Radiotherapy in Non-metastatic Rectal Cancer: a 14-year Nationwide Overview from the Netherlands
10. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer
11. Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design
12. BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer
13. The value of case reports in rare oncological scenarios: mixed method analysis of colorectal metastases from breast cancer
14. Long-Term Outcome of Sustained Endocrine Monotherapy for Elderly Breast Cancer Patients
15. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer
16. Relations between recurrence risk perceptions and fear of cancer recurrence in breast cancer survivors
17. The impact of standardized structured reporting of pathology reports for breast cancer care
18. Shared-care survivorship program for testicular cancer patients: safe and feasible
19. Predictors of delayed breast reconstruction in the Netherlands: a 5-year follow-up study in stage I–III breast cancer patients
20. The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands
21. The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients
22. [18F]FDG PET/CT in the staging of inflammatory breast cancer: A systematic review
23. Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer
24. The INFLUENCE 3.0 model: updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy
25. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer
26. Continuity of care for patients with de novo metastatic cancer during the COVID-19 pandemic: A population-based observational study
27. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer
28. The effect of breast MRI on disease-free and overall survival in breast cancer patients: a retrospective population-based study
29. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study
30. Validating a generic cancer consumer quality index in eight European countries, patient reported experiences and the influence of cultural differences
31. Patient-reported health problems and healthcare use after treatment for early-stage breast cancer
32. The European study on centralisation of childhood cancer treatment
33. Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors
34. P12 Screen-Detected Breast Cancers Have Improved 5-Year Disease Free Interval Compared to Interval and Non-Screen-Related Breast Cancer, Taking Lead Time into Account
35. HSD38 From Unpersonalized to Personalized Breast Follow-up in Clinical Practice in the Netherlands: Will Artificial Intelligence Make a Difference?
36. Breast cancer–related deaths according to grade in ductal carcinoma in situ: A Dutch population–based study on patients diagnosed between 1999 and 2012
37. Centralisation of cancer surgery and the impact on patients’ travel burden
38. Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison
39. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
40. The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors
41. Risk of Positive Sentinel Lymph Node After Neoadjuvant Systemic Therapy in Clinically Node-Negative Breast Cancer: Implications for Postmastectomy Radiation Therapy and Immediate Breast Reconstruction
42. The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
43. Patients' experiences with decisions on timing of chemotherapy for breast cancer
44. Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study
45. Kankerepidemiologie: incidentie, prevalentie, sterfte en verwachtingen
46. Stratified Breast Cancer Follow-Up Using a Partially Observable MDP
47. Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit
48. Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population
49. Impact of gene-expression profiling in patients with early breast cancer when applied outside the guideline directed indication area
50. Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.